Anti-GRHL1 monoclonal antibody

Pre-made anti-GRHL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GRHL1/GRHL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0947-Ab-1/ GM-Tg-hg-IP0947-Ab-2Anti-Human GRHL1 monoclonal antibodyHuman
GM-Tg-rg-IP0947-Ab-1/ GM-Tg-rg-IP0947-Ab-2Anti-Rat GRHL1 monoclonal antibodyRat
GM-Tg-mg-IP0947-Ab-1/ GM-Tg-mg-IP0947-Ab-2Anti-Mouse GRHL1 monoclonal antibodyMouse
GM-Tg-cynog-IP0947-Ab-1/ GM-Tg-cynog-IP0947-Ab-2Anti-Cynomolgus/ Rhesus macaque GRHL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0947-Ab-1/ GM-Tg-felg-IP0947-Ab-2Anti-Feline GRHL1 monoclonal antibodyFeline
GM-Tg-cang-IP0947-Ab-1/ GM-Tg-cang-IP0947-Ab-2Anti-Canine GRHL1 monoclonal antibodyCanine
GM-Tg-bovg-IP0947-Ab-1/ GM-Tg-bovg-IP0947-Ab-2Anti-Bovine GRHL1 monoclonal antibodyBovine
GM-Tg-equg-IP0947-Ab-1/ GM-Tg-equg-IP0947-Ab-2Anti-Equine GRHL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0947-Ab-1/ GM-Tg-hg-IP0947-Ab-2; GM-Tg-rg-IP0947-Ab-1/ GM-Tg-rg-IP0947-Ab-2;
GM-Tg-mg-IP0947-Ab-1/ GM-Tg-mg-IP0947-Ab-2; GM-Tg-cynog-IP0947-Ab-1/ GM-Tg-cynog-IP0947-Ab-2;
GM-Tg-felg-IP0947-Ab-1/ GM-Tg-felg-IP0947-Ab-2; GM-Tg-cang-IP0947-Ab-1/ GM-Tg-cang-IP0947-Ab-2;
GM-Tg-bovg-IP0947-Ab-1/ GM-Tg-bovg-IP0947-Ab-2; GM-Tg-equg-IP0947-Ab-1/ GM-Tg-equg-IP0947-Ab-2
Products NameAnti-GRHL1 monoclonal antibody
Formatmab
Target NameGRHL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GRHL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0947-Ag-1Recombinant multi-species GRHL1/ LBP32/ MGR protein


    Target information

    Target IDGM-IP0947
    Target NameGRHL1
    Gene ID29841,195733,313993,701979,475664,101088233,617248,100072465
    Gene Symbol and SynonymsGRHL1,LBP-32,LBP32,MGR,NH32,Tcfcp2l2,TFCP2L2
    Uniprot AccessionQ9NZI5
    Uniprot Entry NameGRHL1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134317
    Target ClassificationN/A

    The target: GRHL1, gene name: GRHL1, also named as LBP32, MGR, NH32, TFCP2L2. This gene encodes a member of the grainyhead family of transcription factors. The encoded protein can exist as a homodimer or can form heterodimers with sister-of-mammalian grainyhead or brother-of-mammalian grainyhead. This protein functions as a transcription factor during development. [provided by RefSeq, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.